April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Diagnostic ability of wide field swept source optical coherence tomography in glaucoma
Author Affiliations & Notes
  • Zhiyong Yang
    Ophthalmology, University of California San Diego, La Jolla, CA
  • Andrew Tathem
    Ophthalmology, University of California San Diego, La Jolla, CA
  • Chunwei Zhang
    Ophthalmology, University of California San Diego, La Jolla, CA
    Ophthalmology, Harbin Medical University, First Affiliated Hospital, Harbin, China
  • Linda M Zangwill
    Ophthalmology, University of California San Diego, La Jolla, CA
  • Robert N Weinreb
    Ophthalmology, University of California San Diego, La Jolla, CA
  • Felipe A Medeiros
    Ophthalmology, University of California San Diego, La Jolla, CA
  • Footnotes
    Commercial Relationships Zhiyong Yang, None; Andrew Tathem, Heidelberg engineering (F); Chunwei Zhang, None; Linda Zangwill, Carl Zeiss Meditec Inc. (F), Heidelberg Engineering GmbH (F), Nidek Inc. (F), Optovue Inc. (F), Topcon Medical Systems Inc. (F); Robert Weinreb, Aerie (F), Alcon (F), Allergan (F), Bausch & Lomb (F), Carl Zeiss Meditec (F), Carl Zeiss Meditec (F), Genentech (F), Heidelberg Engineering Inc. (F), National Eye Institute (F), Nidek (F), Novartis (F), Optovue (F), Sensimed (F), Topcon (F); Felipe Medeiros, Alcon Laboratories Inc. (F), Allergan Inc. (F), Bausch&Lomb (F), Carl Zeiss Meditec Inc. (F), Heidelberg Engineering Inc. (F), Merck Inc. (F), National Eye Institute (F), Novartis (F), Reichert Inc. (F), Sensimed (F), Topcon Inc. (F)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4736. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Zhiyong Yang, Andrew Tathem, Chunwei Zhang, Linda M Zangwill, Robert N Weinreb, Felipe A Medeiros, ; Diagnostic ability of wide field swept source optical coherence tomography in glaucoma. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4736.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Deep Range Imaging Optical Coherence Tomography (DRI-OCT) is a new swept-source device that provides the ability to image a large retinal area (12 x 9 mm) in a single scan. The purpose of this study was to evaluate the diagnostic ability of wide-field DRI-OCT in glaucoma.

Methods: A cross-sectional observational study of 172 glaucomatous eyes of 117 subjects and 96 eyes of 57 healthy subjects enrolled in the Diagnostic Innovations in Glaucoma Study. Glaucoma was defined by the presence of ≥2 consecutive abnormal standard automated perimetry results or progressive glaucomatous change on masked grading of stereophotographs. Global and sectorial retinal nerve fiber layer (RNFL) thickness were assessed using DRI-OCT. Area under the receiver operating characteristic curves (AROC) were calculated to determine the ability of DRI-OCT to differentiate glaucomatous and healthy eyes.

Results: The average DRI-OCT global RNFL thickness (entire 12 x 9 mm scan) was 51.5 ± 6.5 μm in healthy eyes versus 35.6 ± 9.9 μm in glaucoma (P < 0.001). Average DRI-OCT peripapillary RNFL thickness was 104.6 ± 17.2 μm and 68.7 ± 22.8 μm in healthy and glaucomatous eyes (P < 0.001), respectively. DRI-OCT global RNFL thickness had an AUC of 0.88, which was similar to peripapillary RNFL thickness using the Spectralis OCT circle scan (AROC of 0.88). The best performing parameter was DRI-OCT RNFL thickness of the temporal retina (AROC = 0.90).

Conclusions: DRI-OCT is a promising new technology in the diagnosis of glaucoma that allows imaging of a wide retinal area using a single scan protocol.

Keywords: 552 imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • 550 imaging/image analysis: clinical • 610 nerve fiber layer  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×